| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 44 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2019 | Cotroneo Pat | SVP, Finance And CFO | Sell | 3,201 | $43.12 | $138,027.12 | -1.3% | |
| Jun 14, 2019 | Yu K Peony | Chief Medical Officer | Sale+OE | 3,420 | $40.96 | $140,083.20 | -1.8% | |
| Jun 6, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $37.86 | $227,144.82 | -9.1% | |
| Jun 6, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $38.21 | $1,514,451.84 | -0.4% | |
| May 23, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $35.37 | $1,402,044.68 | -0.5% | |
| May 14, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $36.34 | $1,440,554.02 | -0.3% | |
| May 8, 2019 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $45.94 | $275,621.92 | -11.0% | |
| May 8, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $46.41 | $522,070.00 | -1.4% | |
| May 7, 2019 | Schoeneck James A47 | Director | Sale+OE | 2,000 | $47.02 | $94,045.00 | -20.2% | |
| Apr 18, 2019 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $46.76 | $1,853,490.57 | -0.3% |